Clinical Research Directory
Browse clinical research sites, groups, and studies.
Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer
Sponsor: Mayo Clinic
Summary
This clinical trial compares the use of quantitative transmission imaging (QTI) to standard of care MRI as a supplemental screening tool for patients with a high lifetime risk of breast cancer. QTI is a single 3D ultrasound test intended to be used as an initial evaluation method for asymptomatic women identified with above-average risk for developing breast cancer. Using QTI may be an effective supplemental screening tool, compared to MRI for patients with a high lifetime risk of breast cancer.
Official title: Quantitative Transmission Imaging Evaluation (QTIE Study) Compared With MRI as Supplemental Screening in Patients With High Lifetime Risk of Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2025-07-31
Completion Date
2025-10-20
Last Updated
2026-05-27
Healthy Volunteers
Yes
Conditions
Interventions
QT Ultrasound Breast Scanner
Undergo Quantitative Transmission Imaging (QTI) using the QT Ultrasound Breast Scanner
Questionnaire Administration
Ancillary studies
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States